Gabapentin
- Product NDC
- 66336-439
- 11-digit product format
- 663360439
- Labeler code
- 66336
- Product ID
- 66336-439_7d9f35d2-ad0e-415c-b145-10382b7b5a7f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Dispensing Solutions, Inc.
- Application
- ANDA078150
- Marketing category
- ANDA
- Marketing start
- 2007-07-09
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66336-439-55 | Gabapentin | 150 in 1 BOTTLE | CAPSULE | 150 | | 2 |
| 66336-439-62 | Gabapentin | 180 in 1 BOTTLE | CAPSULE | 180 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66336-439 | GABAPENTIN CAPSULE [DISPENSING SOLUTIONS, INC.] | 2 | Legacy NDC, 2 package rows | 20130814_f4cb6e7e-7041-4753-8192-35a73ef9782f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 66336-439-55 | 66336043955 | 150 in 1 BOTTLE | Historical |
| 66336-439-62 | 66336043962 | 180 in 1 BOTTLE | Historical |